Regional Blood Flow Clinical Trial
Official title:
Effects of Indomethacin on Retinal and Choroidal Blood Flow in Healthy Volunteers
Prostaglandins (PG) are known to alter regional ocular blood flow and exhibit vasoactive
properties in isolated ocular blood vessels. A variety of animal experiments indicate that
endogenous PGs play a role in the regulation of retinal (RBF) and choroidal (ChBF) blood
flow. There is also evidence that the prostaglandin pathway is involved in the activation of
NO production in humans, however, the mechanisms for interactions between PG and NO in
ocular vasculature are still unclear.
Animal studies suggest that retinal and choroidal blood flow decrease after administration
of indomethacin (a nonspecific cyclooxygenase inhibitor). More recently, it has been shown
that indomethacin injected intravenously decreased optic nerve oxygen tension and reduced
the CO2 reactivity. This is probably the result of decreased blood flow through
vasoconstriction of vessels in the optic nerve. Systemic administration of indomethacin also
diminishes cerebral, renal and mesenteric blood flow by an unknown mechanism. However, no
clinical trials exist so far investigating the effects of indomethacin on ocular blood flow.
Therefore, the aim of this study is to investigate the effect of indomethacin on ocular
blood flow in healthy humans.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double-Blind
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01734616 -
Dysfunction of Nutritive Blood Flow as a Determinant of Anabolic Resistance in Older People
|
N/A | |
Completed |
NCT00431691 -
Effect of Antioxidants on Ocular Blood Flow, Endothelial Function, and Cytokine Levels in LPS Induced Inflammatory Model in Humans.
|
Phase 4 | |
Completed |
NCT00810927 -
Role of Nitrogen Oxide (NO) in the Control of Choroidal Blood Flow During a Decrease in Ocular Perfusion Pressure
|
Phase 2 | |
Completed |
NCT00431392 -
Mechanisms of Choroidal Blood Flow Changes During Dark/Light Transitions
|
Phase 2 | |
Completed |
NCT00540215 -
GLP-2 (Glucagonlike Peptide-2) and Blood Flow
|
N/A | |
Completed |
NCT02589054 -
Regional Changes in Upper Limb Perfusion Following Brachial Plexus Block: A Pilot Study
|
N/A | |
Completed |
NCT00707226 -
Circadian Variations in Ocular Blood Flow in Glaucomatous and Normal Eyes
|
N/A | |
Completed |
NCT00709449 -
An Open Study Comparing the Effects of Moxaverine on Ocular Blood Flow in Patients With Age- Related Macular Degeneration, Primary Open Angle Glaucoma and Healthy Control Subjects
|
Phase 2/Phase 3 | |
Terminated |
NCT00708357 -
Does eNOS Gene Polymorphism Play a Role in the Maintenance of Basal Vascular Tone in the Choroid or Optic Nerve Head?
|
Phase 0 | |
Terminated |
NCT00709657 -
The Effect of a Single Intravitreal Anti-VEGF Therapy on Optic Nerve Head Perfusion
|
N/A | |
Completed |
NCT00709423 -
Effects of Moxaverine and Placebo on Ocular Blood Flow
|
Phase 2 | |
Completed |
NCT00814008 -
The Relationship Between Stage of Diabetic Retinopathy and Retinal Blood Flow in Patients With IDDM During Euglycemic Clamp
|
Phase 2 | |
Completed |
NCT00708929 -
Does Complement Factor H Gene Polymorphism Play a Role in the Regulation of Vascular Tone in the Choroid?
|
N/A | |
Completed |
NCT00712400 -
Effects of Latanoprost on Choroidal Blood Flow Regulation in Human Subjects
|
N/A | |
Completed |
NCT00312325 -
Effect of High-Dose Prednisolone (Solu Dacortin®) Treatment on Choroidal and Optic Nerve Head Blood Flow in Humans
|
Phase 4 | |
Withdrawn |
NCT00312390 -
Amblyopia and Neurovascular Coupling in the Retina of Humans
|
N/A | |
Withdrawn |
NCT00406731 -
Role of Endothelin- and Nitric Oxide-system in the Regulation of Optic Nerve Head Blood Flow During Changes in Ocular Perfusion Pressure
|
Phase 2 | |
Completed |
NCT00312416 -
Effects of Topical Clonidine vs. Brimonidine on Choroidal Blood Flow and Intraocular Pressure During Isometric Exercise
|
Phase 4 | |
Completed |
NCT00712907 -
Effects of Vitamin C on Hyperoxia-Induced Reduction of Retinal Blood Flow
|
N/A | |
Withdrawn |
NCT02978560 -
Indocyanine Green Tissue Perfusion Monitoring
|